Nidhi Sahni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nidhi Sahni has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Gloria M. Sheynkman
Department of Molecular Physiology and Biological Physics, University of Virginia , Charlottesville, VA 22903
1 shared publication - Jennifer A. Korchak
Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL 32224, USA
1 shared publication - Neil L. Kelleher
Northwestern University
1 shared publication S. Stephen Yi
Department of Neurosurgery, Baylor Research Institute and Baylor College of Medicine, Temple, USA
1 shared publication
Latest Publications
- Top Cited Papers
- 5 January 2026
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 27 (4) , 271-291
Proteoform medicine: characterizing and targeting protein forms in human disease
Proteoforms are the diverse molecular protein species produced from a single gene through genetic variation, alternative splicing and post-translational modifications. They are the crucial link between genotype and phenotype. There are estimated to be more than one million distinct protein variants produced from ~20,000 protein-coding genes in a given cell, making these proteoforms a vast and largely uncharacterized dimension in biomedical research. This Review focuses on the role of proteoforms in human genetic diseases. We highlight cutting-edge technologies for the identification and characterization of proteoforms, including long-read transcriptomics and emerging methods for direct protein sequencing, and we present a network biology framework to explain how proteoforms can perturb the molecular interactions and cellular pathways underlying disease phenotypes. We believe that precision medicine will require precision proteomics. An increasing knowledge of proteoform biology from molecular, systems and clinical perspectives will guide future research, ultimately contributing to a more precise understanding of the molecular basis of disease and refined therapeutic interventions.
- 5 January 2026
- Published by Springer Nature in Nature Reviews Genetics
- Vol. 27 (4) , 271-291
Top Cited PapersProteoform medicine: characterizing and targeting protein forms in human disease
Proteoforms are the diverse molecular protein species produced from a single gene through genetic variation, alternative splicing and post-translational modifications. They are the crucial link between genotype and phenotype. There are estimated to be more than one million distinct protein variants produced from ~20,000 protein-coding genes in a given cell, making these proteoforms a vast and largely uncharacterized dimension in biomedical research. This Review focuses on the role of proteoforms in human genetic diseases. We highlight cutting-edge technologies for the identification and characterization of proteoforms, including long-read transcriptomics and emerging methods for direct protein sequencing, and we present a network biology framework to explain how proteoforms can perturb the molecular interactions and cellular pathways underlying disease phenotypes. We believe that precision medicine will require precision proteomics. An increasing knowledge of proteoform biology from molecular, systems and clinical perspectives will guide future research, ultimately contributing to a more precise understanding of the molecular basis of disease and refined therapeutic interventions.